Stereotaxis STXS
NYSE STXS
$1.01 +0.02 (+1.70%)
As of: Oct 23, 2026 · 3:59 PM EDT

Stereotaxis (STXS) Short-term Investments (2022 - 2023)

Updated

Stereotaxis (STXS) recorded Short-term Investments of $20.04 million in Q1 2023, up 1.0% from the prior quarter.

Analysis

Stereotaxis (STXS) Short-term Investments (2022 - 2023) Analysis & Trends

At the end of FY2022, Stereotaxis reported Short-term Investments of $19.84 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Stereotaxis 102.03 Mn 102.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 20.04 Mn
Dec 31, 2022 19.84 Mn
API Access

Stereotaxis Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=STXS&period=max&api_key=YOUR_API_KEY